Authors: Vriesendorp, HM Quadri, SM

Citation: Hm. Vriesendorp et Sm. Quadri, Radiolabeled immunoglobulin therapy in patients with Hodgkin's disease, CANC BIO R, 15(5), 2000, pp. 431-445

Authors: Borchardt, PE Quadri, SM Freedman, RS Vriesendorp, HM

Citation: Pe. Borchardt et al., Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis, CANC BIO R, 15(1), 2000, pp. 53-64

Authors: Lai, J Quadri, SM Borchardt, PE Harris, L Wucher, R Askew, E Schweichler, L Vriesendorp, HM

Citation: J. Lai et al., Pharmacokinetics of radiolabeled polyclonal antiferritin in patients with Hodgkin's disease, CLIN CANC R, 5(10), 1999, pp. 3315S-3323S

Authors: Vriesendorp, HM Quadri, SM Wyllie, CT Lai, J Borchardt, PE Harris, L Wucher, R Askew, E Schweichler, L

Citation: Hm. Vriesendorp et al., Fractionated radiolabeled antiferritin therapy for patients with recurrentHodgkin's disease, CLIN CANC R, 5(10), 1999, pp. 3324S-3329S

Authors: Quadri, SM Vriesendorp, HM

Citation: Sm. Quadri et Hm. Vriesendorp, Effects of linker chemistry on the pharmacokinetics of radioimmunoconjugates, Q J NUCL M, 42(4), 1998, pp. 250-261